Are LYCA insiders buying or selling?

Over the last 90 days, LYCA insiders were net buyers, reporting $338,885,022 of open-market purchases and $0.00 of sales.

When was the last LYCA insider purchase?

The most recent open-market purchase of Lycia Therapeutics, Inc. stock by an insider was reported on Oct 27, 2026, one of 9 purchases in the last 90 days.

Where does LYCA insider trading data come from?

Watch Insiders reads the SEC Form 4 filings that Lycia Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.

LYCASector not reported

Lycia Therapeutics, Inc. (LYCA) Insider Trading

In the last 90 days, 9 Lycia Therapeutics, Inc. (LYCA) insiders reported 9 open-market purchases totaling $338,885,022 and no sales. The most recent open-market purchase was reported on Oct 27, 2026. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers: 0
90-day purchase value: $338,885,022
Corporate buyers: 9
Latest transaction: Oct 27, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
Date	Insider name	Role	Type	Shares	Price	Total value
Oct 27, 2026	Bong Y Koh	Corporate insider	Open Market Purchase	2,045,440	$18.41	$37,653,891
Oct 27, 2026	Nimish P Shah	Corporate insider	Open Market Purchase	2,045,440	$18.41	$37,653,891
Oct 27, 2026	Venrock Healthcare Capital Partners III L.P.	10% Owner	Open Market Purchase	2,045,440	$18.41	$37,653,891
Oct 27, 2026	VHCP Management III LLC	Corporate insider	Open Market Purchase	2,045,440	$18.41	$37,653,891
Oct 27, 2026	VHCP Co-Investment Holdings III LLC	Corporate insider	Open Market Purchase	2,045,440	$18.41	$37,653,891
Oct 27, 2026	Venrock Healthcare Capital Partners EG L.P.	Corporate insider	Open Market Purchase	2,045,440	$18.41	$37,653,891
Oct 27, 2026	VHCP Management EG LLC	Corporate insider	Open Market Purchase	2,045,440	$18.41	$37,653,891
Oct 27, 2026	VHCP Management XP LLC	Corporate insider	Open Market Purchase	2,045,440	$18.41	$37,653,891
Oct 27, 2026	Venrock Healthcare Capital Partners XP L.P.	Corporate insider	Open Market Purchase	2,045,440	$18.41	$37,653,891

Common questions

LYCA insider trading FAQ

Are LYCA insiders buying or selling?: Over the last 90 days, LYCA insiders were net buyers, reporting $338,885,022 of open-market purchases and $0.00 of sales.
When was the last LYCA insider purchase?: The most recent open-market purchase of Lycia Therapeutics, Inc. stock by an insider was reported on Oct 27, 2026, one of 9 purchases in the last 90 days.
Where does LYCA insider trading data come from?: Watch Insiders reads the SEC Form 4 filings that Lycia Therapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.